Literature DB >> 27880988

Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: New evidence, new challenges.

Giovanni Musso1, Maurizio Cassader2, Elena Paschetta1, Roberto Gambino2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27880988     DOI： 10.1002/hep.28960

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  7 in total

1.  Inflammation is independent of steatosis in a murine model of steatohepatitis.

Authors:  Wei Wang; Ming-Jiang Xu; Yan Cai; Zhou Zhou; Haixia Cao; Partha Mukhopadhyay; Pal Pacher; Shusen Zheng; Frank J Gonzalez; Bin Gao
Journal:  Hepatology       Date:  2017-05-18       Impact factor: 17.425

2.  Rosiglitazone alleviates intrahepatic cholestasis induced by α-naphthylisothiocyanate in mice: The role of circulating 15-deoxy-Δ12,14 -PGJ2 and Nogo.

Authors:  Shuang Zhang; Miao Yu; Fangling Guo; Xiaoxiao Yang; Yuanli Chen; Chuanrui Ma; Qi Li; Zhuo Wei; Xiaoju Li; Hua Wang; Huaqing Hu; Yujue Zhang; Derun Kong; Qing Robert Miao; Wenquan Hu; David P Hajjar; Yan Zhu; Jihong Han; Yajun Duan
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

3.  Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real-world data analysis.

Authors:  Santo Colosimo; Federico Ravaioli; Maria L Petroni; Lucia Brodosi; Francesca Marchignoli; Francesca A Barbanti; Anna S Sasdelli; Giulio Marchesini; Loris Pironi
Journal:  Liver Int       Date:  2021-02-10       Impact factor: 5.828

4.  Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1.

Authors:  Raghd Abu Helal; Lucia Russo; Hilda E Ghadieh; Harrison T Muturi; Suman Asalla; Abraham D Lee; Cara Gatto-Weis; Sonia M Najjar
Journal:  Metabolism       Date:  2021-05-28       Impact factor: 13.934

Review 5.  From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options.

Authors:  Amalia Gastaldelli; Kenneth Cusi
Journal:  JHEP Rep       Date:  2019-07-19

6.  Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO).

Authors: 
Journal:  Eat Weight Disord       Date:  2021-12-16       Impact factor: 3.008

Review 7.  Dysregulated lipid metabolism links NAFLD to cardiovascular disease.

Authors:  Audrey Deprince; Joel T Haas; Bart Staels
Journal:  Mol Metab       Date:  2020-10-01       Impact factor: 8.568
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.